Atezolizumab (Tecentriq) approved in combination with bevacizumab (Avastin) for the treatment of patients with unresectable or metastatic hepatocellular carcinoma who have not received prior systemic therapy.
 

In 2017 alone, there was an estimated 785 fewer cancer deaths in states that adopted Medicaid expansion.

At 5 years follow up, the data showed that the OS for women on olaparib was 42.1%, while the placebo OS was 33.2%.

Pharmacy experts discuss advancements and updates in therapies for chronic lymphocytic leukemia (CLL). 

Pharmacy Times® spoke with Jennifer Craig, PharmD, CSP, about Skin Cancer Awareness Month and the importance of skin care.

The researchers looked into the lifestyle habits of 6000 participants and found that individuals who consumed food rich in vitamin E had a decreased risk of a memory-robbing condition.

Officials from the FDA have approved flortaucipir F18 (Tauvid, Eli Lilly) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer disease in the brain called tau pathology.

Palforzia is an oral immunotherapy agent for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.
 

Treatment of COVID-19 with both hydroxychloroquine and azithromycin also was strongly associated with increased risk of death.

Artificial intelligence will inevitably play a major role in hub services, improving efficiency and speed to therapy.